Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.640
-0.100 (-5.75%)
Jan 8, 2026, 4:00 PM EST - Market closed
Company Description
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras Al Khaimah, the United Arab Emirates.
Apimeds Pharmaceuticals US, Inc.
| Country | United Arab Emirates |
| Founded | 2020 |
| IPO Date | May 9, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Vinod Menon |
Contact Details
Address: B4-204A5, Business Centre 04, RAKEZ Business Zone-FZ Ras Al Khaimah United Arab Emirates | |
| Website | mindwavedao.com |
Stock Details
| Ticker Symbol | APUS |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 1894525 |
| CUSIP Number | 03771D102 |
| ISIN Number | US03771D1028 |
| Employer ID | 85-1099700 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Vinod Menon | Chief Executive Officer |
| Captain Sandeep Yadav | Chief Operating Officer |
| Amardeep Singh | Chief Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 2, 2026 | 8-K | Current Report |
| Dec 10, 2025 | 8-K | Current Report |
| Dec 10, 2025 | 8-K/A | [Amend] Current report |
| Dec 2, 2025 | 425 | Filing |
| Dec 2, 2025 | 8-K | Current Report |
| Nov 18, 2025 | 8-K | Current Report |
| Nov 12, 2025 | 10-Q | Quarterly Report |
| Oct 16, 2025 | 8-K | Current Report |
| Aug 19, 2025 | 10-Q | Quarterly Report |
| Aug 14, 2025 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |